← Leaderboards
Ronald C Rubenstein
University Of Pennsylvania
$6,263,079
Attributed
$6,263,079
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $869K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,263,079 · 7
By mechanism
R01$5,983,426 · 3
M01$279,653 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Edward J Delikatny$8,977,180
- Jane B Alavi$1,520,103
- Nirinjini N Naidoo$10,036,000
- Takashi Yonetani$3,299,552
- Stephen B Pickup$998,058
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisChloride ChannelsEndoplasmic ReticulumHuman SubjectPhenylbutyratesClinical ResearchEpithelialCystic Fibrosis Transmembrane Conductance RegulatorMutantTraffickingMolecular ChaperonesProteinsIon TransportHuman Therapy EvaluationEpithelial CellsSodium ChannelRegulationCell MembraneRepairedEnac (Epithelial Na+ Channel)Cystic Fibrosis AirwayApicalEpitheliumRestoration
Grant awards (32)
ERP29: PROMOTING ION CHANNEL BIOGENESIS FROM THE ER LUMEN$394,660
R01 · FY2020 · HL · contact PI
ERp29: promoting ion channel biogenesis from the ER lumen$420,000
R01 · FY2019 · HL · contact PI
ERp29: promoting ion channel biogenesis from the ER lumen$420,000
R01 · FY2018 · HL · contact PI
ERp29: promoting ion channel biogenesis from the ER lumen$420,000
R01 · FY2017 · HL · contact PI
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate$354,210
R01 · FY2012 · DK · contact PI
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate$354,210
R01 · FY2011 · DK · contact PI
Regulatory Interactions of CFTR and ENaC$411,250
R01 · FY2010 · DK · contact PI
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate$357,788
R01 · FY2010 · DK · contact PI
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate$100,000
R01 · FY2010 · DK · contact PI
Regulatory Interactions of CFTR and ENaC$411,250
R01 · FY2009 · DK · contact PI
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate$305,415
R01 · FY2008 · DK · contact PI
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate$311,648
R01 · FY2007 · DK · contact PI
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate$320,956
R01 · FY2006 · DK · contact PI
DeltaF508-CFTR Trafficking Regulated by 4-Phenylbutyrate$328,680
R01 · FY2005 · DK
A PILOT TRIAL OF PHENYLBUTYRATE/GENISTEIN DUOTHERAPY (FOR CYSTIC FIBROSIS)$4,731
M01 · FY2005 · RR
PHENYLBUTYRATE/GENISTEIN DUOTHERAPY IN DELTAF508 HETEROZYGOTES$3,441
M01 · FY2005 · RR
DELTAF508-CFTR TRAFFICKING REGULATED BY 4-PHENYLBUTYRATE$72,399
R01 · FY2004 · DK
A pilot trial of phenylbutyrate/genistein duotherapy (for Cystic Fibrosis)$12,986
M01 · FY2004 · RR
Phenylbutyrate/Genistein Duotherapy in deltaF508 Heterozygotes$10,203
M01 · FY2004 · RR
DELTAF508-CFTR TRAFFICKING REGULATED BY 4-PHENYLBUTYRATE$255,000
R01 · FY2003 · DK
DELTAF508-CFTR TRAFFICKING REGULATED BY 4-PHENYLBUTYRATE$255,000
R01 · FY2002 · DK
CYSTIC FIBROSIS LUNG DISEASE USING A 3RD GENERATION ADENOVIRUS$124,146
M01 · FY2002 · RR
CAMP STIMULATED SWEAT RATE IN CYSTIC FIBROSIS$0
M01 · FY2002 · RR
DELTAF508-CFTR TRAFFICKING REGULATED BY 4-PHENYLBUTYRATE$255,000
R01 · FY2001 · DK
CYSTIC FIBROSIS LUNG DISEASE USING A 3RD GENERATION ADENOVIRUS$124,146
M01 · FY2001 · RR
CYSTIC FIBROSIS LUNG DISEASE USING A 3RD GENERATION ADENOVIRUS$0
M01 · FY2001 · RR
CAMP STIMULATED SWEAT RATE IN CYSTIC FIBROSIS$0
M01 · FY2001 · RR
DELTAF508-CFTR TRAFFICKING REGULATED BY 4-PHENYLBUTYRATE$235,960
R01 · FY2000 · DK
CYSTIC FIBROSIS LUNG DISEASE USING A 3RD GENERATION ADENOVIRUS$0
M01 · FY2000 · RR
CAMP STIMULATED SWEAT RATE IN CYSTIC FIBROSIS$0
M01 · FY2000 · RR
CYSTIC FIBROSIS LUNG DISEASE USING A 3RD GENERATION ADENOVIRUS$0
M01 · FY2000 · RR
CYSTIC FIBROSIS LUNG DISEASE USING A 3RD GENERATION ADENOVIRUS$0
M01 · FY2000 · RR